{"pmid":32342252,"pmcid":"PMC7185831","title":"Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.","text":["Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.","In a preliminary clinical study, we observed that the combination of hydroxychloroquine and azithromycin was effective against SARS-CoV-2 by shortening the duration of viral load in Covid-19 patients. It is of paramount importance to define when a treated patient can be considered as no longer contagious. Correlation between successful isolation of virus in cell culture and Ct value of quantitative RT-PCR targeting E gene suggests that patients with Ct above 33-34 using our RT-PCR system are not contagious and thus can be discharged from hospital care or strict confinement for non-hospitalized patients.","Eur J Clin Microbiol Infect Dis","La Scola, Bernard","Le Bideau, Marion","Andreani, Julien","Hoang, Van Thuan","Grimaldier, Clio","Colson, Philippe","Gautret, Philippe","Raoult, Didier","32342252"],"abstract":["In a preliminary clinical study, we observed that the combination of hydroxychloroquine and azithromycin was effective against SARS-CoV-2 by shortening the duration of viral load in Covid-19 patients. It is of paramount importance to define when a treated patient can be considered as no longer contagious. Correlation between successful isolation of virus in cell culture and Ct value of quantitative RT-PCR targeting E gene suggests that patients with Ct above 33-34 using our RT-PCR system are not contagious and thus can be discharged from hospital care or strict confinement for non-hospitalized patients."],"journal":"Eur J Clin Microbiol Infect Dis","authors":["La Scola, Bernard","Le Bideau, Marion","Andreani, Julien","Hoang, Van Thuan","Grimaldier, Clio","Colson, Philippe","Gautret, Philippe","Raoult, Didier"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342252","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1007/s10096-020-03913-9","keywords":["co-culture","correlation","covid-19","rt-pcr","sars-cov2","viral load"],"e_drugs":["Hydroxychloroquine","Azithromycin"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495035375617,"score":9.490897,"similar":[{"pmid":32221523,"pmcid":"PMC7184442","title":"Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients.","text":["Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients.","BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a public health emergency. The widely used reverse transcription PCR (RT-PCR) method has limitations for clinical diagnosis and treatment. METHODS: A total of 323 samples from 76 COVID-19 confirmed patients were analyzed by droplet digital PCR (ddPCR) and RT-PCR based two target genes (ORF1ab and N). Nasal swabs, throat swabs, sputum, blood, and urine were collected. Clinical and imaging data were obtained for clinical staging. RESULTS: In 95 samples tested positive by both methods, the cycle threshold (Ct) of RT-PCR was highly correlated with the copy numbed of ddPCR (ORF1ab gene, R2 = 0.83; N gene, R2 = 0.87). 4 (4/161) negative and 41 (41/67) single-gene positive samples tested by RT-PCR were positive according to ddPCR with viral load ranging from 11.1 to 123.2 copies/test. Then the viral load of respiratory samples was compared and the average viral load in sputum (17429 +/- 6920 copies/test) was found to be significantly higher than in throat swabs (2552 +/- 1965 copies/test, p < 0.001) and nasal swabs (651 +/- 501 copies/test, p < 0.001). Furthermore, the viral load in the early and progressive stages were significantly higher than that in the recovery stage (46800 +/- 17272 vs 1252 +/- 1027, p < 0.001) analyzed by sputum samples. CONCLUSIONS: Quantitative monitoring of viral load in lower respiratory tract samples helps to evaluate disease progression, especially in cases of low viral load.","Clin Infect Dis","Yu, Fengting","Yan, Liting","Wang, Nan","Yang, Siyuan","Wang, Linghang","Tang, Yunxia","Gao, Guiju","Wang, Sa","Ma, Chengjie","Xie, Ruming","Wang, Fang","Tan, Chianru","Zhu, Lingxiang","Guo, Yong","Zhang, Fujie","32221523"],"abstract":["BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a public health emergency. The widely used reverse transcription PCR (RT-PCR) method has limitations for clinical diagnosis and treatment. METHODS: A total of 323 samples from 76 COVID-19 confirmed patients were analyzed by droplet digital PCR (ddPCR) and RT-PCR based two target genes (ORF1ab and N). Nasal swabs, throat swabs, sputum, blood, and urine were collected. Clinical and imaging data were obtained for clinical staging. RESULTS: In 95 samples tested positive by both methods, the cycle threshold (Ct) of RT-PCR was highly correlated with the copy numbed of ddPCR (ORF1ab gene, R2 = 0.83; N gene, R2 = 0.87). 4 (4/161) negative and 41 (41/67) single-gene positive samples tested by RT-PCR were positive according to ddPCR with viral load ranging from 11.1 to 123.2 copies/test. Then the viral load of respiratory samples was compared and the average viral load in sputum (17429 +/- 6920 copies/test) was found to be significantly higher than in throat swabs (2552 +/- 1965 copies/test, p < 0.001) and nasal swabs (651 +/- 501 copies/test, p < 0.001). Furthermore, the viral load in the early and progressive stages were significantly higher than that in the recovery stage (46800 +/- 17272 vs 1252 +/- 1027, p < 0.001) analyzed by sputum samples. CONCLUSIONS: Quantitative monitoring of viral load in lower respiratory tract samples helps to evaluate disease progression, especially in cases of low viral load."],"journal":"Clin Infect Dis","authors":["Yu, Fengting","Yan, Liting","Wang, Nan","Yang, Siyuan","Wang, Linghang","Tang, Yunxia","Gao, Guiju","Wang, Sa","Ma, Chengjie","Xie, Ruming","Wang, Fang","Tan, Chianru","Zhu, Lingxiang","Guo, Yong","Zhang, Fujie"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32221523","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1093/cid/ciaa345","keywords":["covid-19","rt-pcr","sars-cov-2","viral load","ddpcr"],"topics":["Diagnosis"],"weight":1,"_version_":1666138492270280705,"score":271.62225},{"pmid":32442256,"title":"Predicting infectious SARS-CoV-2 from diagnostic samples.","text":["Predicting infectious SARS-CoV-2 from diagnostic samples.","BACKGROUND: RT-PCR has become the primary method to diagnose viral diseases, including SARS-CoV-2. RT-PCR detects RNA, not infectious virus, thus its ability to determine duration of infectivity of patients is limited. Infectivity is a critical determinant in informing public health guidelines/interventions. Our goal was to determine the relationship between E gene SARS-CoV-2 RT-PCR cycle threshold (Ct) values from respiratory samples, symptom onset to test (STT) and infectivity in cell culture. METHODS: In this retrospective cross-sectional study, we took SARS-CoV-2 RT-PCR confirmed positive samples and determined their ability to infect Vero cell lines. RESULTS: Ninety RT-PCR SARS-CoV-2 positive samples were incubated on Vero cells. Twenty-six samples (28.9%) demonstrated viral growth. Median TCID50/ml was 1780 (282-8511). There was no growth in samples with a Ct > 24 or STT > 8 days. Multivariate logistic regression using positive viral culture as a binary predictor variable, STT and Ct demonstrated an odds ratio for positive viral culture of 0.64 (95% CI 0.49-0.84, p<0.001) for every one unit increase in Ct. Area under the receiver operating characteristic curve for Ct vs. positive culture was OR 0.91 (95% CI 0.85-0.97, p<0.001), with 97% specificity obtained at a Ct of >24. CONCLUSIONS: SARS-CoV-2 Vero cell infectivity was only observed for RT-PCR Ct < 24 and STT < 8 days. Infectivity of patients with Ct >24 and duration of symptoms >8 days may be low. This information can inform public health policy and guide clinical, infection control and occupational health decisions. Further studies of larger size are needed.","Clin Infect Dis","Bullard, Jared","Dust, Kerry","Funk, Duane","Strong, James E","Alexander, David","Garnett, Lauren","Boodman, Carl","Bello, Alexander","Hedley, Adam","Schiffman, Zachary","Doan, Kaylie","Bastien, Nathalie","Li, Yan","Van Caeseele, Paul G","Poliquin, Guillaume","32442256"],"abstract":["BACKGROUND: RT-PCR has become the primary method to diagnose viral diseases, including SARS-CoV-2. RT-PCR detects RNA, not infectious virus, thus its ability to determine duration of infectivity of patients is limited. Infectivity is a critical determinant in informing public health guidelines/interventions. Our goal was to determine the relationship between E gene SARS-CoV-2 RT-PCR cycle threshold (Ct) values from respiratory samples, symptom onset to test (STT) and infectivity in cell culture. METHODS: In this retrospective cross-sectional study, we took SARS-CoV-2 RT-PCR confirmed positive samples and determined their ability to infect Vero cell lines. RESULTS: Ninety RT-PCR SARS-CoV-2 positive samples were incubated on Vero cells. Twenty-six samples (28.9%) demonstrated viral growth. Median TCID50/ml was 1780 (282-8511). There was no growth in samples with a Ct > 24 or STT > 8 days. Multivariate logistic regression using positive viral culture as a binary predictor variable, STT and Ct demonstrated an odds ratio for positive viral culture of 0.64 (95% CI 0.49-0.84, p<0.001) for every one unit increase in Ct. Area under the receiver operating characteristic curve for Ct vs. positive culture was OR 0.91 (95% CI 0.85-0.97, p<0.001), with 97% specificity obtained at a Ct of >24. CONCLUSIONS: SARS-CoV-2 Vero cell infectivity was only observed for RT-PCR Ct < 24 and STT < 8 days. Infectivity of patients with Ct >24 and duration of symptoms >8 days may be low. This information can inform public health policy and guide clinical, infection control and occupational health decisions. Further studies of larger size are needed."],"journal":"Clin Infect Dis","authors":["Bullard, Jared","Dust, Kerry","Funk, Duane","Strong, James E","Alexander, David","Garnett, Lauren","Boodman, Carl","Bello, Alexander","Hedley, Adam","Schiffman, Zachary","Doan, Kaylie","Bastien, Nathalie","Li, Yan","Van Caeseele, Paul G","Poliquin, Guillaume"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32442256","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/cid/ciaa638","keywords":["covid-19","rt-pcr","sars-cov-2","infectivity","public health"],"topics":["Diagnosis"],"weight":1,"_version_":1667523504865542144,"score":235.77196},{"pmid":32419639,"title":"Viral loads in throat and anal swabs in children infected with SARS-CoV-2.","text":["Viral loads in throat and anal swabs in children infected with SARS-CoV-2.","Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay on anal swabs was recently reported to be persistently positive even after throat testing was negative during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, data about the consistent performance of RT-PCR assay on throat and anal swabs remain limited in pediatric patients. Here, we retrospectively reviewed RT-PCR-testing results of 212 pediatric patients with suspected SARS-CoV-2 infection at Wuhan Children's Hospital. The diagnostic potential of these two types of specimens were showed significant difference (positive rate: 78.2% on throat swabs vs. 52.6% on anal swabs, McNemar Test P=0.0091) and exhibited a weak positive consistency (Kappa value was 0.311, P<0.0001) in pediatric patients. Furthermore, viral loads detected on both throat and anal swabs also showed no significant difference (P = 0.9511) and correlation (Pearson r = 0.0434, P = 0.8406), and exhibited an inconsistent kinetic change through the course of SARS-CoV-2 infection. Besides, viral loads in the throat and anal swabs were correlated with different types of immune states, immune-reactive phase, and the resolution phase/immunologic tolerance, respectively. These findings revealed that RT-PCR-testing on throat and anal swabs showed significant difference for monitoring SARS-CoV-2 infection and correlated with different immune state in pediatric patients.","Emerg Microbes Infect","Yuan, Chunhui","Zhu, Hongmin","Yang, Yuan","Cai, Xiaonan","Xiang, Feiyan","Wu, Huan","Yao, Cong","Xiang, Yun","Xiao, Han","32419639"],"abstract":["Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay on anal swabs was recently reported to be persistently positive even after throat testing was negative during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, data about the consistent performance of RT-PCR assay on throat and anal swabs remain limited in pediatric patients. Here, we retrospectively reviewed RT-PCR-testing results of 212 pediatric patients with suspected SARS-CoV-2 infection at Wuhan Children's Hospital. The diagnostic potential of these two types of specimens were showed significant difference (positive rate: 78.2% on throat swabs vs. 52.6% on anal swabs, McNemar Test P=0.0091) and exhibited a weak positive consistency (Kappa value was 0.311, P<0.0001) in pediatric patients. Furthermore, viral loads detected on both throat and anal swabs also showed no significant difference (P = 0.9511) and correlation (Pearson r = 0.0434, P = 0.8406), and exhibited an inconsistent kinetic change through the course of SARS-CoV-2 infection. Besides, viral loads in the throat and anal swabs were correlated with different types of immune states, immune-reactive phase, and the resolution phase/immunologic tolerance, respectively. These findings revealed that RT-PCR-testing on throat and anal swabs showed significant difference for monitoring SARS-CoV-2 infection and correlated with different immune state in pediatric patients."],"journal":"Emerg Microbes Infect","authors":["Yuan, Chunhui","Zhu, Hongmin","Yang, Yuan","Cai, Xiaonan","Xiang, Feiyan","Wu, Huan","Yao, Cong","Xiang, Yun","Xiao, Han"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419639","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1080/22221751.2020.1771219","keywords":["rt-pcr","sars-cov-2","diagnostic potential","pediatric patients","viral load"],"topics":["Diagnosis"],"weight":1,"_version_":1667159284538933248,"score":230.44537},{"pmid":32438868,"title":"ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens.","text":["ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens.","Quantitative real time PCR (RT-PCR) is widely used as the gold standard for clinical detection of SARS-CoV-2. However, due to the low viral load specimens and the limitations of RT-PCR, significant numbers of false negative reports are inevitable, which results in failure to timely diagnose, early treat, cut off transmission, and assess discharge criteria. To improve this situation, an optimized droplet digital PCR (ddPCR) was used for detection of SARS-CoV-2, which showed that the limit of detection of ddPCR is significantly lower than that of RT-PCR. We further explored the feasibility of ddPCR to detect SARS-CoV-2 nucleic acid from 77 clinical throat swabs, and compared with RT-PCR in terms of the diagnostic accuracy based on the results of follow-up survey. According to our study, 26 samples from COVID-19 patients with negative RT-PCR reports were detected as positive by ddPCR. The sensitivity, specificity, PPV, NPV, negative likelihood ratio (NLR) and accuracy were improved from 40% (95% CI: 27-55%), 100% (95% CI: 54-100%), 100%, 16% (95% CI: 13-19%), 0.6 (95% CI: 0.48-0.75) and 47% (95% CI: 33-60%) for RT-PCR to 94% (95% CI: 83-99%), 100% (95% CI: 48-100%), 100%, 63% (95% CI: 36-83%), 0.06 (95% CI: 0.02-0.18) and 95% (95% CI: 84-99%) for ddPCR, respectively. Moreover, 6/14 (42.9%) convalescents were detected as positive by ddPCR, which still carry detectable SARS-CoV-2 at 5-12 days post discharge. Overall, ddPCR shows superiority for clinical diagnosis of SARS-CoV-2 to reduce the false negative reports, which could be a powerful complement to the current standard RT-PCR.","Emerg Microbes Infect","Suo, Tao","Liu, Xinjin","Feng, Jiangpeng","Guo, Ming","Hu, Wenjia","Guo, Dong","Ullah, Hafiz","Yang, Yang","Zhang, Qiuhan","Wang, Xin","Sajid, Muhanmmad","Huang, Zhixiang","Deng, Liping","Chen, Tielong","Liu, Fang","Xu, Ke","Liu, Yuan","Zhang, Qi","Liu, Yingle","Xiong, Yong","Chen, Guozhong","Lan, Ke","Chen, Yu","32438868"],"abstract":["Quantitative real time PCR (RT-PCR) is widely used as the gold standard for clinical detection of SARS-CoV-2. However, due to the low viral load specimens and the limitations of RT-PCR, significant numbers of false negative reports are inevitable, which results in failure to timely diagnose, early treat, cut off transmission, and assess discharge criteria. To improve this situation, an optimized droplet digital PCR (ddPCR) was used for detection of SARS-CoV-2, which showed that the limit of detection of ddPCR is significantly lower than that of RT-PCR. We further explored the feasibility of ddPCR to detect SARS-CoV-2 nucleic acid from 77 clinical throat swabs, and compared with RT-PCR in terms of the diagnostic accuracy based on the results of follow-up survey. According to our study, 26 samples from COVID-19 patients with negative RT-PCR reports were detected as positive by ddPCR. The sensitivity, specificity, PPV, NPV, negative likelihood ratio (NLR) and accuracy were improved from 40% (95% CI: 27-55%), 100% (95% CI: 54-100%), 100%, 16% (95% CI: 13-19%), 0.6 (95% CI: 0.48-0.75) and 47% (95% CI: 33-60%) for RT-PCR to 94% (95% CI: 83-99%), 100% (95% CI: 48-100%), 100%, 63% (95% CI: 36-83%), 0.06 (95% CI: 0.02-0.18) and 95% (95% CI: 84-99%) for ddPCR, respectively. Moreover, 6/14 (42.9%) convalescents were detected as positive by ddPCR, which still carry detectable SARS-CoV-2 at 5-12 days post discharge. Overall, ddPCR shows superiority for clinical diagnosis of SARS-CoV-2 to reduce the false negative reports, which could be a powerful complement to the current standard RT-PCR."],"journal":"Emerg Microbes Infect","authors":["Suo, Tao","Liu, Xinjin","Feng, Jiangpeng","Guo, Ming","Hu, Wenjia","Guo, Dong","Ullah, Hafiz","Yang, Yang","Zhang, Qiuhan","Wang, Xin","Sajid, Muhanmmad","Huang, Zhixiang","Deng, Liping","Chen, Tielong","Liu, Fang","Xu, Ke","Liu, Yuan","Zhang, Qi","Liu, Yingle","Xiong, Yong","Chen, Guozhong","Lan, Ke","Chen, Yu"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32438868","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1080/22221751.2020.1772678","keywords":["rt-pcr","sars-cov-2","clinical detection","droplet digital pcr"],"topics":["Diagnosis"],"weight":1,"_version_":1667523504860299264,"score":218.65483},{"pmid":32246822,"pmcid":"PMC7184485","title":"Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads.","text":["Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads.","BACKGROUND: Corona Virus Disease-2019 (COVID-19) has spread widely throughout the world since the end of 2019. Nucleic acid testing (NAT) has played an important role in patient diagnosis and management of COVID-19. In some circumstances, thermal inactivation at 56 degrees C has been recommended to inactivate Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) before NAT. However, this procedure could theoretically disrupt nucleic acid integrity of this single-stranded RNA virus and cause false negatives in real-time polymerase chain reaction (RT-PCR) tests. METHODS: We investigated whether thermal inactivation could affect the results of viral NAT. We examined the effects of thermal inactivation on the quantitative RT-PCR results of SARS-CoV-2 particularly with regard to the rates of false-negative results for specimens carrying low viral loads. We additionally investigated the effects of different specimen types, sample preservation times and a chemical inactivation approach on NAT. RESULTS: Our work showed increased Ct values in specimens from diagnosed COVID-19 patients in RT-PCR tests after thermal incubation. Moreover, about half of the weak-positive samples (7 of 15 samples, 46.7%) were RT-PCR negative after heat inactivation in at least one parallel testing. The use of guanidinium-based lysis for preservation of these specimens had a smaller impact on RT-PCR results with fewer false negatives (2 of 15 samples, 13.3%) and significantly less increase in Ct values than heat inactivation. CONCLUSION: Thermal inactivation adversely affected the efficiency of RT-PCR for SARS-CoV-2 detection. Given the limited applicability associated with chemical inactivators, other approaches to ensure the overall protection of laboratory personnel need consideration.","Clin Chem","Pan, Yang","Long, Luyao","Zhang, Daitao","Yan, Tingting","Cui, Shujuan","Yang, Peng","Wang, Quanyi","Ren, Simei","32246822"],"abstract":["BACKGROUND: Corona Virus Disease-2019 (COVID-19) has spread widely throughout the world since the end of 2019. Nucleic acid testing (NAT) has played an important role in patient diagnosis and management of COVID-19. In some circumstances, thermal inactivation at 56 degrees C has been recommended to inactivate Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) before NAT. However, this procedure could theoretically disrupt nucleic acid integrity of this single-stranded RNA virus and cause false negatives in real-time polymerase chain reaction (RT-PCR) tests. METHODS: We investigated whether thermal inactivation could affect the results of viral NAT. We examined the effects of thermal inactivation on the quantitative RT-PCR results of SARS-CoV-2 particularly with regard to the rates of false-negative results for specimens carrying low viral loads. We additionally investigated the effects of different specimen types, sample preservation times and a chemical inactivation approach on NAT. RESULTS: Our work showed increased Ct values in specimens from diagnosed COVID-19 patients in RT-PCR tests after thermal incubation. Moreover, about half of the weak-positive samples (7 of 15 samples, 46.7%) were RT-PCR negative after heat inactivation in at least one parallel testing. The use of guanidinium-based lysis for preservation of these specimens had a smaller impact on RT-PCR results with fewer false negatives (2 of 15 samples, 13.3%) and significantly less increase in Ct values than heat inactivation. CONCLUSION: Thermal inactivation adversely affected the efficiency of RT-PCR for SARS-CoV-2 detection. Given the limited applicability associated with chemical inactivators, other approaches to ensure the overall protection of laboratory personnel need consideration."],"journal":"Clin Chem","authors":["Pan, Yang","Long, Luyao","Zhang, Daitao","Yan, Tingting","Cui, Shujuan","Yang, Peng","Wang, Quanyi","Ren, Simei"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32246822","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1093/clinchem/hvaa091","keywords":["covid-19","false negative","nucleic acid test","rt-pcr","sars-cov-2","thermal inactivation"],"e_drugs":["Guanidine"],"topics":["Diagnosis"],"weight":1,"_version_":1666138492054274048,"score":192.69066}]}